MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, PMI had $2,403K increase in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
$2,403K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Income tax provision
-0
Derivative loss
-2,505
Net loss
-10,426 -12,285
Depreciation and amortization
123 82
Amortization of right of use asset
86 173
Amortization of discount on debt issued
4,524 2,371
Derivative loss
-7,040 -
Provision for excess and obsolete inventory
643 464
Stock-based compensation
528 324
Accounts receivable
-408 787
Inventory
-266 -655
Prepaid expenses and other assets
105 -130
Accounts payable
-2,173 1,077
Accrued expenses and other liabilities
318 701
Operating lease obligation
-92 -192
Net cash used in operating activities
-6,514 -4,782
Net cash used in investing activities
0 -
Proceeds from loans from related parties
1,156 1,752
Repayments of loans from related parties
8,124 90
Issuance of convertible notes
0 2,000
Payments of convertible notes
25 -
Proceeds from issuance of common stock
13,724 1,485
Proceeds from subscription of common stock
2,235 -
Repayment of finance lease obligations
52 35
Net cash provided by financing activities
8,949 5,112
Effect of exchange rate changes on cash and cash equivalents
-48 -16
Net increase (decrease) in cash and cash equivalents
2,403 314
Cash and cash equivalents at beginning of period
96 -
Cash and cash equivalents at end of period
2,813 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Picard Medical, Inc. (PMI)

Picard Medical, Inc. (PMI)